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PAXX was identified recently as a novel nonhomologous
end-joining DNA repair factor in human cells. To charac-
terize its physiological roles, we generated Paxx-deficient
mice. LikeXlf−/−mice, Paxx−/−mice are viable, grownor-
mally, and are fertile but show mild radiosensitivity.
Strikingly, while Paxx loss is epistatic with Ku80, Lig4,
and Atm deficiency, Paxx/Xlf double-knockout mice dis-
play embryonic lethality associated with genomic insta-
bility, cell death in the central nervous system, and an
almost complete block in lymphogenesis, phenotypes
that closely resemble those of Xrcc4−/− and Lig4−/−
mice. Thus, combined loss of Paxx andXlf is synthetic-le-
thal in mammals.
Supplemental material is available for this article.
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DNA double-strand breaks (DSBs) are extremely toxic le-
sions that must be repaired for an organism to pass on its
genetic material intact to the next generation (Jackson
and Bartek 2009). Cells have evolved two principal DSB re-
pair pathways to address this challenge: homologous re-
combination (HR) and nonhomologous end-joining
(NHEJ).HR is restricted to S andG2phases of the cell cycle
because it requires a sister chromatid as the template for
repair. In contrast, NHEJ is the dominant DSB repair path-
way throughout interphase inmammalian cells, although
it is restrained during DNA replication (Beucher et al.
2009; Karanam et al. 2012). NHEJ is initiated by Ku, a
ring-shaped heterodimeric protein complex consisting of
Ku70 and Ku80 subunits that specifically recognizes DSB
ends (Grundy et al. 2014). Ku forms a platform for the
downstream recruitment of core NHEJ factors such as
DNA ligase IV (LIG4); its stable binding partner, XRCC4;
and XLF, a protein structurally related to XRCC4 (Ochi
et al. 2014).
Most DSBs in vertebrate cells are generated by agents
such as ionizing radiation (IR) or molecules that directly
damage DNA by chemically reacting with it or through
processing of other DNA lesions during DNA replication
or mitosis. Additionally, some DSBs are induced deliber-
ately by enzymatic cleavage in certain cell types at vari-
ous stages of development; for example, to generate
immune receptor diversity in B and T lymphocytes during
variable, diversity, and joining [V(D)J] recombination
(Jackson and Bartek 2009). NHEJ plays a central role in
V(D)J recombination, a fact highlighted by the severe im-
munodeficiency found in some human patients and mice
with NHEJ defects (Woodbine et al. 2014).
Mouse models of NHEJ deficiency show both overlap-
ping and unique features. Ku-deficient mice are subviable
and fertile but have profound growth defects, increased
neuronal cell death, and immunodeficiency (Nussenz-
weig et al. 1996; Zhu et al. 1996; Ouyang et al. 1997; Gu
et al. 2000). Loss of Xrcc4 or Lig4 results in a more severe
phenotype with embryonic growth defects, blocked lym-
phogenesis, and late embryonic lethality associated with
a large increase in cell death in the developing central ner-
vous system (CNS) (Barnes et al. 1998; Frank et al. 1998;
Gao et al. 1998). In contrast, Xlf−/−mice have a relatively
mild phenotype with no growth defects, neuronal cell
death, or overt immunodeficiency despite XLF being a
core NHEJ factor (Ahnesorg et al. 2006; Buck et al. 2006;
Li et al. 2008). Furthermore, Xlf−/− B cells perform V(D)J
recombination at almost wild-type levels, which explains
the lack of significant immunodeficiency in these mice
and suggests that compensatory mechanisms can miti-
gate loss of XLF in developing lymphocytes. One of these
mechanisms comprises the ATM–H2AX–53BP1 axis of
DSB repair, as combined loss of any one of these factors
with XLF deficiency causes profound defects in V(D)J re-
combination and lymphocyte development even though
loss of any of these proteins individually is not signifi-
cantly detrimental to these processes (Zha et al. 2011;
Liu et al. 2012; Oksenych et al. 2012).
Recently, we and others identified a third XRCC4-like
NHEJ protein, called PAXX (Craxton et al. 2015; Ochi
et al. 2015; Xing et al. 2015). PAXX is required for cellular
resistance to DSB-inducing agents and is rapidly recruited
to DNA damage sites, where it stabilizes NHEJ factors on
chromatin and promotes DNA repair by NHEJ. In vitro,
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PAXX can stimulate DNA end ligation in the presence of
LIG4, XRCC4, and Ku, with most if not all of these func-
tions requiring its direct binding to Ku. However, it is still
unknownwhether PAXX functions similarly to other core
NHEJ factors in physiological settings or how PAXX loss
might impact at the organism level in terms of growth
and development.
In this study, we describe the generation and character-
ization of PAXX-deficientmice. LikeXlf−/−mice, Paxx−/−
mice are viable, grow normally, and are fertile. However,
these mice are radiosensitive and show a mild reduction
in splenic lymphocyte numbers. Strikingly, combined
loss of Paxx and Xlf is synthetic-lethal, as the majority
of double-knockout embryos dies before birth with signif-
icant growth defects, increased genomic instability and
subsequent cell death in the developing CNS, and an al-
most complete block in lymphocyte development, pheno-
types that are strongly reminiscent of Xrcc4−/− or Lig4−/−
mice. Thus, PAXX and XLF share a redundant function
that is critical for DNA repair during mammalian
development.
Results and Discussion
Generation of Paxx−/− mice
To characterize PAXX function in mice, we disrupted the
Paxx locus in C57BL/6NTac zygotes using CRISPR–Cas9
(Wright et al. 2016) by injection of wild-type Cas9 mRNA
together with two small guide RNAs (sgRNAs) and an ol-
igonucleotide template to collapse the entire Paxx geno-
mic region, resulting in a 1.6-kb deletion (Fig. 1A). For
ease of mutant selection when using Cas9, Paxx sgRNAs
were coinjectedwith an sgRNA to disrupt exon 1 of the ty-
rosinase gene (Tyr) to yield an albino phenotype in suc-
cessfully targeted mice (Supplemental Fig. S1A,B). We
identified four Paxx F0 founders, all of which showed
the albino phenotype (Supplemental Fig. S2A,B). Upon
confirmation of Paxx locus deletion by PCR and sequenc-
ing (Supplemental Fig. S2C), we backcrossed founders to
the C57BL/6NTac original background for three genera-
tions to segregate the Tyr deletion and any off-target mu-
tations. Resulting mice showed complete absence of
PAXX protein in tissues such as thymus, lung, and brain
that normally highly express Paxx (Fig. 1A).
Paxx−/−mice were born at the expected Mendelian fre-
quencies, were fertile, and displayed no developmental or
hematological abnormalities (Supplemental Fig. S2D,E;
Supplemental Table S1). Paxx−/−mice also showed no in-
creased tumor predisposition up to 400 d (data not shown)
and no significant increase in micronucleus formation
(Supplemental Fig. S3A), a sensitive method for detecting
genomic instability in vivo (Balmus et al. 2015).
Paxx−/− mice are radiosensitive but show no overt
immune phenotype
In light of the immune defects of NHEJ-deficient mouse
models, we examined whether Paxx−/− mice displayed
anyovert immunodeficiencybyanalyzing leukocytenum-
bers. We detected a modest reduction in cell counts in the
spleens of Paxx−/− mice compared with wild-type litter-
mates, but this was not observed in the thymus or bone
marrow (Fig. 1B). Splenic cell reduction was due to de-
creased B-cell and T-cell populations, while the NK cell
lineage was not significantly affected (Fig. 1C). T-cell de-
velopment in the thymus (as measured by CD4 and CD8
expression) was essentially normal in Paxx−/−mice (Sup-
plemental Fig. S3B), although they did exhibit a small in-
crease in the number and percentage of mature B cells
within the bone marrow (Supplemental Fig. S3C; data
not shown). To test whether Paxx−/− mice were capable
of mounting a proper immune response, we immunized
Paxx−/− and wild-type littermates with purified fragment
C of tetanus toxin and found that immune responses as
measured by total immunoglobulin (Ig), IgG1, and IgG2a
antibody titers were similar in both (Supplemental Fig.
S3D). Furthermore, class switch recombination (CSR)
was normal in the absence of PAXX (Supplemental Fig.
S3E). As PAXX is important for efficient DSB repair in hu-
man cells (Craxton et al. 2015; Ochi et al. 2015; Xing et al.
2015), we treated Paxx−/−mice with IR. Following whole-
body IR treatment, we observed significantly increased le-
thality in Paxx−/− mice when compared with wild-type
controls, although this was not as dramatic as that ob-
served inAtm−/−mice (Fig. 1D; Barlow et al. 1996). Taken
together, these data implied that although PAXX is impor-
tant for effective DSB repair, it does not play an essential
role in mammalian development and is unlikely to func-
tion as a strong tumor suppressor. In addition, Paxx−/−
mice showed only a mild reduction in lymphocyte
Figure 1. Paxx−/−mice are viable and show increased sensitivity to
IR. (A) Schematic representation of the CRISPR design deployed to
delete the entire coding sequence of thePaxx locus onmouse chromo-
some 2. Representative Western blot showing PAXX protein level in
wild-type versus Paxx knockout thymi, lungs, and brains. β-Actin
was the loading control. (B) Paxx−/−mice showa significant reduction
of total cell numbers in the spleen ([∗∗∗∗] P < 0.0001, Student’s t test; 6-
wk-old femalemice;mean ± SD)butnot in the thymusorbonemarrow
whencomparedwithPaxx+/+mice. (C ) B-cell andT-cell distribution in
the spleens of Paxx+/+ as compared with Paxx−/− littermate mice.
(∗∗∗) P < 0.001; (∗) P < 0.05, Student’s t test. Mean ± SD. Leukocytes
were identifiedasCD45+.BcellsweredefinedasCD19+withthesubsets
on the basis of CD21 and CD23 expression. (Follicular B) CD23 +
CD21low/neg; (marginal zone B) CD23low/neg CD21high; (transitional B)
CD23low CD21low. NK cells were defined as NK1.1+ CD3−, and T cells
were defined asCD3+NK1.1−withT-cell subsets on thebasis of surface
CD4 or CD8 expression. (D) Mice (12–14wk old) of the indicated geno-
typeswereexposedto5Gyofwhole-bodyIR.Kaplan-Meyerχ2statistical
analysis showednolethality inPaxx+/+micebut increasedsensitivityto
IR in Paxx−/−mice.Atm−/−micewere used as positive controls.
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numbers and displayed no overt immunodeficiency phe-
notype. In this regard,Paxx−/−micemost closely resemble
Xlf−/− mice (Li et al. 2008) rather than mice deficient in
other core NHEJ factors.
Paxx loss is epistatic with Ku, Lig4, and Atm deficiency
Genetic crosses between NHEJ mutant mice and with
other DNA repair-deficient mouse models have revealed
both synthetic viability (e.g., Ku80−/− Lig4−/− mice) and
synthetic lethality (e.g.,Atm−/−Xlf−/−mice) relationships
(Karanjawala et al. 2002; Zha et al. 2011). Such genetic
crosses can highlight antagonistic roles and/or functional
redundancies between DNA repair factors and can help
position such factors in NHEJ and other events. We there-
fore crossed our Paxx−/− mice into Ku80-deficient, Lig4-
deficient, Atm-deficient, or Xlf-deficient backgrounds.
Paxx−/− Ku80−/−mice were born at frequencies similar
to Ku80−/− mice and did not show any overt phenotypes
compared with Ku80−/− animals (Fig. 2A; Supplemental
Table S2A), consistent with Paxx being epistatic with
Ku80 in regard to NHEJ. Notably, this was similar to
what we observed with Xlf−/− Ku80−/− mice, which also
closely resemble Ku80−/− mice (Supplemental Fig. S4A,
B). In contrast to Ku80−/− mice, Lig4−/− mice die during
embryonic development in a manner associated with dra-
matically increased apoptosis in the CNS (Barnes et al.
1998; Frank et al. 1998; Gao et al. 1998). As Ku80 loss res-
cues the lethality of Lig4−/−mice (Karanjawala et al. 2002)
and because PAXX functions in physical contact with Ku
inNHEJ, wewonderedwhether PAXX losswould result in
a similar rescue.However,multiple rounds of breeding did
not produce any viable Paxx−/− Lig4−/− offspring, indicat-
ing that, unlike Ku80 loss, PAXX loss cannot rescue the
embryonic lethality caused by LIG4 deficiency (Fig. 2B;
Supplemental Table S2B). Next, we generated Paxx−/−
Atm−/−mice to explore potential functional relationships
between these two genes. Notably, in contrast to the rela-
tionship between Atm and Xlf (Zha et al. 2011), Paxx−/−
Atm−/− mice displayed no additional phenotypes com-
pared with Atm−/− mice (Fig. 2C; Supplemental Fig. S5;
Supplemental Table S2C), indicating that Paxx and Atm
are epistatic for immune functions such as CSR and dur-
ing development.
Paxx loss is synthetic-lethal with Xlf deficiency
Wealso crossedPaxx−/−micewithXlf−/−mice to examine
potential functional relationships between these genes.
Strikingly, these double-knockoutmicewere dramatically
underrepresented, with only one Paxx−/− Xlf−/− mouse
born out of 25 expected (Fig. 2D; Supplemental Table
S2D). Furthermore, this mouse was born smaller and, at
5 d of age, was clearly distinguishable from its littermate
controls (Supplemental Fig. S6A). By 10 d of age, this
Paxx−/− Xlf−/−mouse failed to thrive and, at necropsy, ex-
hibited amicrospleen and a complete absence of a thymus,
similar towhat is observed inKu80−/− animals (Fig. 2E). In
accordwith these findings, therewas a significant decrease
in splenic cell counts relative to body weight, and, upon
red blood cell lysis, no lymphocytes were recovered (Sup-
plemental Fig. S6B,C). Taken together, these data indicat-
ed that while Paxx loss is epistatic with Ku80, Lig4, and
Atm in terms of its developmental roles, it is synthetic-le-
thal in combination with Xlf loss.
To determine when Paxx−/− Xlf−/−mice die during em-
bryonic development, we established timed matings and
performed embryo dissections starting at embryonic day
9.5 (E9.5) when Paxx/Xlf double mutants showed no gross
abnormalities (Supplemental Fig. S7A). ByE10.5, although
double mutants were recovered at the expected frequen-
cies, more than half of the Paxx−/− Xlf−/− embryos were
smaller than their littermate controls (Fig. 3A; Supple-
mental Fig. S7B). Nevertheless, the Paxx/Xlf double mu-
tants were not developmentally delayed at this stage,
showing somite numbers similar to those of wild-type,
Paxx−/−, or Xlf−/− embryos (Fig. 3B), thus hinting at a pos-
sible cell fate abnormality. Similarly, at E14.5, double-mu-
tant embryos were obtained at the expected Mendelian
frequencies (Fig. 3C; Supplemental Table S3A) but were
smaller than controls (Fig. 3D,E). By E18.5, Paxx−/−
Xlf−/− double mutants were no longer obtained at the ex-
pected frequencies, and a significant proportion of them
was found to have died (Fig. 3F; Supplemental Table
S3B). A few were viable but showed reduced body weight,
much smaller spleens, and a drastic involution of the thy-
mus (Fig. 3G–I), thus highlighting a requirement for either
PAXX or XLF in lymphatic organ development and for life
for more than a few days postnatally.
Figure 2. Paxx/Xlf deficiency leads to a synthetic-lethal phenotype.
Mice were genotyped using ear snip biopsies, and expected versus ob-
served numbers were used to calculate χ2. Bar graphs presenting se-
lected genotype combinations are presented. (A) Paxx/Ku80-
deficient mice are significantly underrepresented compared with
wild-type mice (∗∗P < 0.01) but are represented at ratios similar to
that of Ku80 deficiency alone ([∗∗∗∗] P < 0.0001). (B) Paxx deficiency
cannot save the Lig4-associated lethality. Neither Lig4−/− nor
Paxx−/− Lig4−/− mice are born. (∗∗∗∗) P < 0.0001. (C ) Paxx deficiency
does not modify the phenotypes associated with Atm loss. Like
Atm−/−mice, Paxx−/− Atm−/−mice are born at the expected Mende-
lian frequencies. (D) Unlike Paxx−/− or Xlf−/− mice, Paxx−/−Xlf−/−
mice are not born at the expected frequencies. (∗∗∗∗) P < 0.0001. (E)
Photograph of a 10-d-old Paxx−/− Xlf−/− mouse as compared with a
Paxx+/+ Xlf−/− littermate control. Isolated spleens and thymus of
the represented mice are shown. In the case of the Paxx−/− Xlf−/−
mouse no thymus was identified.
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To determine the cause of embryonic death in Paxx−/−
Xlf−/−mice, we looked for markers of genomic instability
(phosphorylated histone H2AX; γH2AX) and apoptosis
(cleaved caspase 3) in E10.5 and E14.5 embryos via immu-
nohistochemistry. At both E10.5 and E14.5, we consis-
tently observed an increase in γH2AX-positive cells in
the CNS of the Paxx−/− Xlf−/− double-mutant mice as
compared with littermate controls (Fig. 4A,B; Supplemen-
tal Fig. S7C). This was associated with increased apopto-
sis, as evidenced by the accumulation of cleaved caspase
3, especially in the cortical plate region of the cerebral cor-
tex (Fig. 4B; Supplemental Fig. S7C,D). In contrast, signif-
icant increases in these markers were not detected in
most other tissues (Supplemental Fig. S8A,B). Together,
these findings highlighted a critical requirement for
Paxx or Xlf for development of not only lymphatic organs
but also the CNS. We thus conclude that lack of effective
maintenance of genome stability during development re-
sults in increased cell death and embryonic lethality in
the absence of both PAXX and XLF.
In this study, we described the generation of
PAXX-deficient mice. We found that while
Paxx−/− mice are radiosensitive, they are born
atMendelian ratios and display no overt immu-
nodeficiency or developmental defects. In this
regard, Paxx−/− mice are reminiscent of Xlf−/−
mice, although the immunological phenotype
of the latter is slightly more pronounced (Li
et al. 2008). Furthermore, our data support a
model in which PAXX functions in NHEJ in a
manner connected to and dependent on Ku
because Ku80−/− Paxx−/− double-mutant mice
were essentially identical toKu80−/−mice. Fur-
thermore, we found that PAXX loss could not
rescue the embryonic lethality phenotype of
Lig4−/−mice. This was expected based on previ-
ous cell-based studies and biochemical analyses
of PAXX, which showed that PAXX functions
downstream from Ku in the NHEJ process, be-
ing recruited to Ku-bound DNA ends by direct
binding of the PAXX C terminus to Ku (Ochi
et al. 2015; Xing et al. 2015).
Perhaps surprisingly, we found that com-
bined PAXX and XLF deficiency is lethal in
mice. This was unexpected based on our previ-
ous results in human cells, where we found
that depletion of XLF in PAXX−/− RPE-1 cells
caused no additional radiosensitivity (Ochi
et al. 2015). Interestingly, we were able to reca-
pitulate this epistasis in mouse embryonic fi-
broblasts (MEFs) derived from our Paxx/Xlf
single-knockout and double-knockout mice ex-
posed to IR and the radiomimetic drug phleo-
mycin (Supplemental Fig. S9A–C). Due to the
extensive cell death in lymphoid progenitors
in developing embryos, we were unable to iso-
late B cells from Paxx−/−Xlf−/−mice to examine
their radiosensitivity in vitro. However, recent
data using Paxx/Xlf single-knockout and dou-
ble-knockout v-Abl transformed pro-B cells de-
rived from wild-type mice demonstrated that,
in this cell lineage as in the developing CNS, a
synthetic relationship between PAXX and XLF
exists in terms of cellular sensitivity to IR as
well as in the process of V(D)J recombination
(Kumar et al. 2016; Lescale et al. 2016b). Thus,
there appears to be a tissue-specific requirement for
PAXX and XLF: In some cells, both PAXX and XLF are re-
quired for NHEJ, but, in others, either one or the other suf-
fices to a major degree. In this regard, we note that tissue-
specific requirements for XLF in mice have been demon-
strated previously (Li et al. 2008).
Since the generation of XLF-deficient mice was first
reported (Li et al. 2008), it has been unclear why the phe-
notype of these mice is relatively mild compared with
mice in which other core NHEJ factors are mutated giv-
en that XLF is important for DSB repair by NHEJ in cells
(Ahnesorg et al. 2006; Buck et al. 2006). To help explain
these findings, functional redundancy with other factors
was suggested and, in due course, demonstrated by XLF
loss being shown to display nonepistatic or synthetic-le-
thal relationships with loss of components of the ATM–
H2AX–53BP1 pathway or with C-terminal mutants of
the V(D)J recombinase protein RAG2 (Zha et al. 2011;
Liu et al. 2012; Oksenych et al. 2012; Lescale et al.
2016a). Our data reveal that PAXX and XLF also share
Figure 3. Embryonic lethality upon simultaneous loss of Paxx and Xlf. Embryos
from timed matings were isolated at the indicated stage of embryonic development,
imaged for morphological assessment, and genotyped by PCR from the yolk sacs or
tail snips. (A) Representative images of Paxx−/− and Paxx−/− Xlf−/− E10.5 littermate
embryos. (B) Bar graph of somite counts from E10.5 dissected litters. (C ) Bar graph
(mean ± SD) of expected versus observed E14.5 embryos. (D) Representative images
of Paxx−/− and Paxx−/− Xlf−/− E14.5 littermate embryos. (E) Bar graph representing
the percentage relative body weight as compared with control littermates at E14.5.
(∗∗∗∗) P < 0.0001, Student’s t test. (F ) Bar graph of expected versus observed E18.5 em-
bryos. (∗) P < 0.05, Student’s t test. The red bar was added to represent the number of
Paxx−/− Xlf−/− embryos found dead. (G) Representative images of Xlf−/− (left) and
Paxx−/− Xlf−/− E18.5 littermate embryos. (H) Bar graph (mean ± SD) representing
the percentage relative body weight as compared with control littermates at E18.5.
(∗∗) P < 0.01, Student’s t test. (I ) Representative images of thymi and spleens of
Xlf−/− as compared with Paxx−/− Xlf−/− littermate E18.5 live embryos.
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one or more redundant functions, as, unlike single mu-
tants, mice lacking both proteins display severe growth
defects, extensive cell death in the CNS, and an almost
complete block to lymphocyte development similar to
that of Xrcc4−/− or Lig4−/− mice. Interestingly, unlike
the situation when combining XLF and ATM loss, com-
bined loss of PAXX and ATM did not lead to a pheno-
type more severe than that of mice lacking ATM
alone. Considering our findings, it will be of interest to
further explore the overlapping and nonoverlapping
functions of PAXX and XLF in NHEJ during develop-
ment, define the basis for the apparent tissue-specific ef-
fects of their combined loss, and establish how PAXX
might operate in the context of ATM-mediated DSB re-
pair processes.
Materials and methods
Animals
Care and use of all mice used to generate data for this protocol were carried
out in accordance with UK Home Office regulations, UK Animals (Scien-
tific Procedures) Act of 2013. Paxx-deleted (C57BL/6NTac-Paxxem1Gb)
mice were generated using CRISPR/Cas9. Ku80 (B6.129-Xrcc5tm1Nus/J;
stock no: 004361), Lig4 (B6;129S6-Lig4tm1Fwa/Kvm; stock no: 006482),
andAtm (129S6-Atmtm1Awb/J); stock no. 008671) knockout mice were im-
ported from Jackson Laboratories. Xlf (129S6/SvEvTac-Nhej1tm1Fwa)
knockout mice (Li et al. 2008) were imported from the laboratory of Dr.
Shan Zha at Columbia University. The double-mutant combinations
were maintained on the selected mixed backgrounds. For analysis of em-
bryonic development, timed matings were performed. Noon of the day
of vaginal plug detection was defined as E0.5.
IR treatment
For analysis of survival upon IR, mice were subjected to 5 Gy of γ irradia-
tion using a sealed 137Cs source γ irradiator (CIS-IBL 437C). Subsequently,
mice were monitored by daily weighing for up to 30 d or until reaching hu-
mane endpoint criteria based on the clinical disease scoring system de-
tailed in the Supplemental Material.
Histology, immunohistochemistry, and immunoblotting
All major organs were isolated following euthanasia and then fixed in 10%
formalin overnight. Embryos were dissected on cold PBS and fixed in 4%
paraformaldehyde. On the second day, the fixed organs were transferred
to 70% ethanol, placed in cassettes, and embedded in paraffin, and serial
5-µm sections were collected on Superfrost Plus slides (Thermo Fisher Sci-
entific) using a Leica microdissection system (LMD7000). For immunohis-
tochemistry apoptosis and DNA damage, quantitation was done using
antibodies against cleaved caspase 3 (Abcam, ab13847) or γH2AX (clone
JBW301; Millipore), respectively. For Western blotting, antibodies against
PAXX (Abcam, ab126353) and β-actin (Sigma, A5316) were used. Histology
images were obtained using an Aperio Scanscope (Aperio Technologies).
Statistical analysis was performed using Prism 7 (Graphpad). Student’s t
tests were always two-tailed.
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